1. Search Result

Search Result

Targets Recommended: MDM-2/p53

Results for "2060610-53-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-135805

    EGFR Cancer
    JBJ-04-125-02 is a potent, mutant-selective, allosteric and orally active EGFR inhibitor with an IC50 of 0.26 nM for EGFR L858R/T790M. JBJ-04-125-02 can inhibit cancer cell proliferation and EGFR L858R/T790M/C797S signaling. JBJ-04-125-02 has anti-tumor activities.